Highly Z-selective olefin metathesis

US10173208B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10173208-B2
Application numberUS-201715399485-A
CountryUS
Kind codeB2
Filing dateJan 5, 2017
Priority dateSep 30, 2009
Publication dateJan 8, 2019
Grant dateJan 8, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates generally to catalysts and processes for the Z-selective formation of internal olefin(s) from terminal olefin(s) via homo-metathesis reactions.

First claim

Opening claim text (preview).

What is claimed: 1. A method comprising: providing a catalyst having the structure: wherein M is Mo or W; R 1 is aryl, heteroaryl, alkyl, heteroalkyl, optionally substituted; R 2 and R 3 can be the same or different and are hydrogen, alkyl, alkenyl, heteroalkyl, heteroalkenyl, aryl, or heteroaryl, optionally substituted; and R 4 and R 5 can be the same or different and are alkyl, heteroalkyl, aryl, heteroaryl, silylalkyl, or silyloxy, optionally substituted, wherein at least one of R 4 or R 5 is a ligand containing oxygen bound to M; and reacting a first molecule comprising a terminal double bond with a second molecule that comprises a terminal double bond in the presence of the catalyst to produce a product comprising an internal double bond, and wherein the internal double bond of the product comprises one carbon atom from the terminal bond of the first molecule and one carbon atom from the terminal double bond of the second molecule. 2. The method of claim 1 , wherein the first molecule and the second molecule are identical. 3. The method of claim 1 , wherein at least about 30% of the internal double bond of the product is formed as the Z-isomer. 4. The method of claim 1 , wherein the reaction proceeds with a conversion of at least about 30%. 5. The method of claim 1 , wherein at least one of the first and second molecules has the formula: wherein R a is H, alkyl, alkenyl, heteroalkyl, heteroalkenyl, aryl, heteroaryl, or acyl, optionally substituted. 6. The method of claim 1 , wherein one of R 4 and R 5 is a ligand containing oxygen bound to M, optionally substituted, and the other is a ligand containing nitrogen bound to M, optionally substituted. 7. The method of claim 6 , wherein the at least one ligand containing oxygen bound to M lacks a plane of symmetry. 8. The method of claim 6 , wherein the ligand containing nitrogen bound to M is selected from the group consisting of pyrrolyl, pyrazolyl, pyridinyl, pyrazinyl, pyrimidinyl, imidazolyl, triazolyl, tetrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, indolyl, indazolyl, carbazolyl, morpholinyl, piperidinyl, and oxazinyl, all optionally substituted. 9. The method of claim 6 , wherein the ligand containing oxygen bound to M comprises a group having the formula —OSi(R 22 ) 3 , wherein each R 22 can be the same or different and is aryl or alkyl, optionally substituted. 10. The method of claim 6 , wherein the ligand containing nitrogen bound to M has the structure: wherein each R 6 can be the same or different and is hydrogen, alkyl, heteroalkyl, aryl, or heteroaryl, optionally substituted; and X may be present or absent and is any non-interfering group. 11. The method of claim 6 , wherein the ligand containing oxygen bound to M has the following structure: wherein R 7 is aryl, heteroaryl, alkyl, or heteroalkyl, optionally substituted; R 8 is hydrogen, —OH, halogen, alkyl, heteroalkyl, aryl, heteroaryl, acyl, acyloxy, or —OP, optionally substituted; or, together R 7 and R 8 are joined to form a ring, optionally substituted; R 9 is when R 8 is not or —OH, —OP, or amino, optionally substituted; R 10 is hydrogen, halogen, alkyl, heteroalkyl, aryl, heteroaryl, or acyl, optionally substituted; each R 11 , R 12 , R 13 , and R 14 can be the same or different and is aryl, heteroaryl, alkyl, heteroalkyl, or acyl, optionally substituted; or, together R 11 and R 12 are joined to form a ring, optionally substituted; or together R 13 and R 14 are joined to form a ring, optionally substituted; and P is a protecting group. 12. The method of claim 6 , wherein R 4 is a derivative of the following structure: wherein P is a silyl protecting group. 13. The method of claim 1 , wherein R 1 is: wherein each R 17 can be the same or different and is hydrogen, halogen, alkyl, heteroalkyl, aryl, acyl, or —OP, optionally substituted; and P is a protecting group. 14. The method of claim 1 , wherein R 1 is: wherein each R 17 can be the same or different and is hydrogen, halogen, alkyl, heteroalkyl, aryl, acyl, or —OP, optionally substituted; and P is a protecting group. 15. The method of claim 1 , wherein R 1 is wherein each R 17 can be the same or different and is hydrogen, halogen, alkyl, heteroalkyl, aryl, acyl, or —OP, optionally substituted; R 2 is CMe 2 Ph or CMe 3 ; R 3 is H; and R 4 is an enantiomer of the following structure, wherein each R 7 and R 10 is the same or different and is halogen, methyl, t-butyl, CF 3 , or aryl, optionally substituted; and P is a protecting group. 16. The method of claim 15 , wherein R 5 has the following structure: wherein each R 6 can be the same or different and is hydrogen, alkyl, heteroalkyl, aryl, heteroaryl, optionally substituted; and X may be present or absent and is any non-interfering group. 17. The method of claim 6 , wherein the ligand containing oxygen or nitrogen bound to M has the following structure: wherein each R 7 and R 8 can be the same or different and is hydrogen, halogen, alkyl, alkoxy, aryl, acyl, or a protecting group, optionally substituted; R 10 is hydrogen, halogen, alkyl, heteroalkyl, aryl, heteroaryl, or acyl, optionally substituted; each R 11 , R 12 , R 13 , and R 14 can be the same or different and is aryl, heteroaryl, alkyl, heteroalkyl, or acyl, optionally substituted; or, together R 11 and R 12 are joined to form a ring, optionally substituted; or, together R 13 and R 14 are joined to form a ring, optionally substituted; R 15 is alkyl, aryl, or a protection group, optionally substituted; R 16 is hydrogen or an amine protecting group; X can be any non-interfering group;

Assignees

Inventors

Classifications

  • Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine · CPC title

  • containing nitrogen, phosphorus, arsenic or antimony · CPC title

  • Compounds containing elements of Groups 6 or 16 of the Periodic Table · CPC title

  • the other ring being six-membered, e.g. tetraline · CPC title

  • by splitting of carbon-to-carbon bonds and redistribution, e.g. disproportionation or migration of [IMAGE cpc-sch-C07C-0963.gif] groups between different molecules · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10173208B2 cover?
The present invention relates generally to catalysts and processes for the Z-selective formation of internal olefin(s) from terminal olefin(s) via homo-metathesis reactions.
Who is the assignee on this patent?
Massachusetts Inst Technology, Trustees Boston College
What technology area does this patent fall under?
Primary CPC classification B01J31/2295. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).